The Claim
Daily administration of 100 mg enteric-coated aspirin does not significantly reduce the incidence of major adverse cardiovascular events, including fatal coronary heart disease, nonfatal myocardial infarction, or fatal or nonfatal ischemic stroke, in healthy community-dwelling adults aged 70 years and older.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a daily 100 mg aspirin pill does not actually lower the risk of serious heart problems or strokes in healthy seniors over 70. A recent study showed that older adults who took aspirin had almost the same rate of heart events as those who took a placebo.
See the scientific wording
Daily administration of 100 mg enteric-coated aspirin does not significantly reduce the rate of major adverse cardiovascular events, defined as fatal coronary heart disease, nonfatal myocardial infarction, or fatal or nonfatal ischemic stroke, in healthy community-dwelling adults aged 70 years and older. Over a median follow-up of 4.7 years, the event rate was 7.8 per 1000 person-years in the aspirin group versus 8.8 per 1000 person-years in the placebo group, yielding a hazard ratio of 0.89 (95% CI 0.77 to 1.03), confirming the absence of a statistically significant protective effect against ischemic cardiovascular events in this demographic.
What the research says
1 studyStudy: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
The RCT evaluated this non-prespecified endpoint. The confidence interval crossing 1.0 and the lack of statistical significance indicate no causal reduction in ischemic cardiovascular events.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.